Latest news
Vitrafy Life Sciences Reports 80% Revenue Rise and Halved Net Loss in FY2026 Preliminary Final Results - KalkineKalkine · Tue, 04 Aug 2026 03:54:05 GMTVitrafy Life Sciences Schedules FY26 Annual Results Investor Briefing for 4 August 2026 - KalkineKalkine · Mon, 03 Aug 2026 04:22:58 GMTVitrafy Life Sciences (ASX: VFY): Cryo Stock in Focus - KalkineKalkine · Wed, 29 Jul 2026 07:00:00 GMT